title: Isolation and characterization of peroxisome-deficient Chinese hamster ovary cell mutants representing human complementation group III.
abstract: We made use of the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method and isolated peroxisome-deficient mutant cells. TKa cells, the wild-type Chinese hamster ovary (CHO) cells, CHO-K1, that had been stably transfected with cDNA encoding Pex2p (formerly peroxisome assembly factor-1, PAF-1) were used to avoid frequent isolation of the Z65-type, PEX2-defective mutants. P9OH/UV-resistant cell colonies were examined for the intracellular location of catalase, a peroxisomal matrix enzyme, by immunofluorescence microscopy and using anti-catalase antibody. As six mutant cell clones showed cytosolic catalase, there was likely to be a deficiency in peroxisome assembly. These mutants also showed the typical peroxisome assembly-defective phenotype, including significant decrease of dihydroxyacetonephosphate acyltransferase, the first step key enzyme in plasmalogen synthesis, and loss of resistance to 12-(1'-pyrene)dodecanoic acid/UV treatment. By transfection of Pex2p and Pex6p (formerly PAF-2) cDNAs and cell fusion analysis between the CHO cell mutants, two mutants, ZP104 and ZP109, were found to belong to a novel complementation group. Further complementation analysis using fibroblasts from patients with peroxisome biogenesis disorders revealed that the mutants belonged to human complementation group III. Taken together, ZP104 and ZP109 are in a newly identified fifth complementation group in CHO mutants reported to date and represent the human complementation group III.
authors.affiliation: Department of Biology, Kyushu University Faculty of Science, Fukuoka, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Okumoto
authors.forename: A
authors.initials: A
authors.lastname: Bogaki
authors.forename: K
authors.initials: K
authors.lastname: Tateishi
authors.forename: T
authors.initials: T
authors.lastname: Tsukamoto
authors.forename: T
authors.initials: T
authors.lastname: Osumi
authors.forename: N
authors.initials: N
authors.lastname: Shimozawa
authors.forename: Y
authors.initials: Y
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Orii
authors.forename: Y
authors.initials: Y
authors.lastname: Fujiki
mesh_terms: D000074183:ATPases Associated with Diverse Cellular Activities; D000251:Adenosine Triphosphatases / Q000235:genetics*; D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D004351:Drug Resistance; D005816:Genetic Complementation Test; D006801:Humans; D007850:Lauric Acids / Q000494:pharmacology; D008830:Microbodies / Q000235:genetics*; D009154:Mutation; D018901:Peroxisomal Disorders / Q000145:classification / Q000235:genetics*; D015211:Zellweger Syndrome / Q000145:classification / Q000235:genetics*
chemical_list: D007850:Lauric Acids; C040596:12-(1-pyrene)dodecanoic acid; D000251:Adenosine Triphosphatases; D000074183:ATPases Associated with Diverse Cellular Activities; C490759:PEX6 protein, human; C096998:Pex6 protein, rat